Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise-The Energy Report (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Uranium Energy Finds High-Grade Potential in Wyoming

% of readers think this story is Fact. Add your two cents.


Source: Joe Reagor 08/11/2025

Uranium Energy Corp. (UEC:NYSE AMERICAN) shared its financial results for the third quarter of fiscal year 2025, Roth Capital Partners Analyst Joe Reagor wrote in an updated research note on June 3.

Uranium Energy Corp. (UEC:NYSE AMERICAN) shared its financial results for the third quarter of fiscal year 2025 and provided insights into the progress at Christensen Ranch, Roth Capital Partners Analyst Joe Reagor wrote in an updated research note on June 3.

The results aligned closely with expectations, and UEC continues to advance its primary projects. Which is why Reagor said he was maintaining the firm’s Buy rating and maintaining its price target at US$10.50, an 85% increase over the US$5.69 price at the time of writing.

On June 2, 2025, the company disclosed its financial performance for fiscal Q3 2025. As anticipated, the company did not record any uranium sales during this period. Regarding earnings per share, UEC reported a loss of US$0.07, which was wider than Roth’s projected loss of US$0.04. This larger loss was attributed to non-cash losses on equity investments and higher-than-expected general and administrative and mineral property expenses. However, this did not significantly impact our valuation of the company.

Update on Development at Christensen Ranch

Alongside its financial results, UEC provided an update on the ongoing development at Christensen Ranch. Notably, UEC announced the commencement of header house 10-7, marking the first new production header house since the phased restart began. Reagor said he anticipated that UEC is set to dry and drum its first substantial production in fiscal Q4 2025.

Management also gave an update on the construction at Burke Hollow, which is on schedule for initial production in early 2026, in our assessment. Additionally, the company mentioned plans to release a technical report summary (TRS) for the Sweetwater facility, outlining a new hub-and-spoke strategy, Reagor wrote. In line with this plan, UEC has initiated the process of amending permits to incorporate ISR capabilities at the facility. We believe this TRS could serve as a significant catalyst for the company, as it is expected to highlight the potential value of this asset.

The analyst said the firm has updated its model to incorporate Q3 financial results, mark-to-market adjustments on equity holdings, and an increased valuation for Sweetwater. The overall effect of these updates was not significant to our sum-of-the-parts valuation of UEC. Therefore, he said the firm is maintaining its Buy rating and the US$10.50 price target.

Basis for Valuation

Roth’s valuation of UEC was based on a sum-of-the-parts analysis, Reagor said. The firm attributed a value of US$1.03 billion to UEC’s ISR projects, which translates to US$9 per pound of resource, including historical resources from Uranium One.

He wrote the firm estimated US$182 million for the potential addition of 52 million pounds of ISR resources in Wyoming, valued at US$3.50 per pound. The hard rock assets are valued at US$266.9 million, or US$6.50 per pound of resource, and the Oviedo exploration project is valued at US$69.3 million, or US$3 per pound at the lower end of the exploration target.

“Thus, we arrive at a total valuation of US$4.6 billion, or US$10.28 per fully diluted share,” the analyst noted. “We round this up to reach our price target of US$10.50, and we are maintaining our Buy rating.”

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Uranium Energy Corp.
  2. Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
  3. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Disclosures for Roth Capital Partners, Uranium Energy Corp., June 3, 2025:

Within the last twelve months, ROTH Capital Partners, or an affiliate to ROTH Capital Partners, has received compensation for investment banking services from Uranium Energy Corp. ROTH makes a market in shares of Uranium Energy Corp. and as such, buys and sells from customers on a principal basis.

ROTH Capital Partners, LLC expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this report in the next three months. The material, information and facts discussed in this report other than the information regarding ROTH Capital Partners, LLC and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This report should not be used as a complete analysis of the company, industry or security discussed in the report. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in this report are subject to change without notice. An investment in the stock may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Additionally, an investment in the stock may involve a high degree of risk and may not be suitable for all investors. No part of this report may be reproduced in any form without the express written permission of ROTH. Copyright 2025. Member: FINRA/SIPC.

( Companies Mentioned: UEC:NYSE AMERICAN, )


Source: https://www.streetwisereports.com/article/2025/08/11/uranium-energy-finds-high-grade-potential-in-wyoming.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.